Log in to save to my catalogue

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_96e48863d23e4cd690b1a7438e01c591

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study

About this item

Full title

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2019-12, Vol.23 (1), p.400-400, Article 400

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Enrichment strategies improve therapeutic targeting and trial efficiency, but enrichment factors for sepsis trials are lacking. We determined whether concentrations of soluble tumor necrosis factor receptor-1 (sTNFR1), interleukin-8 (IL8), and angiopoietin-2 (Ang2) could identify sepsis patients at higher mortality risk and serve as prognostic enri...

Alternative Titles

Full title

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_96e48863d23e4cd690b1a7438e01c591

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_96e48863d23e4cd690b1a7438e01c591

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1466-609X,1366-609X

DOI

10.1186/s13054-019-2684-2

How to access this item